182 related articles for article (PubMed ID: 16493970)
21. The rise and fall of ciprofloxacin-resistant Neisseria gonorrhoeae in Liverpool.
Corkill JE; Kelly C; Neal T; Alawattegama AB; Hart CA
Int J STD AIDS; 2005 Jan; 16(1):83. PubMed ID: 15705281
[No Abstract] [Full Text] [Related]
22. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006.
Su X; Jiang F; Qimuge ; Dai X; Sun H; Ye S
Sex Transm Dis; 2007 Dec; 34(12):995-9. PubMed ID: 17595594
[TBL] [Abstract][Full Text] [Related]
23. Increasing incidence of ciprofloxacin-resistant Neisseria gonorrhoeae infection in Canada.
Sarwal S; Wong T; Sevigny C; Ng LK
CMAJ; 2003 Apr; 168(7):872-3. PubMed ID: 12668548
[No Abstract] [Full Text] [Related]
24. Fluoroquinolone-resistant Neisseria gonorrhoeae--San Diego, California, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 May; 47(20):405-8. PubMed ID: 9622458
[TBL] [Abstract][Full Text] [Related]
25. High prevalence of high-level ciprofloxacin resistance in Neisseria gonorrhoeae in Tel Aviv, Israel: correlation with response to therapy.
Dan M; Poch F; Sheinberg B
Antimicrob Agents Chemother; 2002 Jun; 46(6):1671-3. PubMed ID: 12019074
[TBL] [Abstract][Full Text] [Related]
26. Fluoroquinolones, gonorrhea, and the CDC STD treatment guidelines.
Berman SM; Moran JS; Wang SA; Workowski KA
Sex Transm Dis; 2003 Jun; 30(6):528-9; author reply 530. PubMed ID: 12782957
[No Abstract] [Full Text] [Related]
27. Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United States.
Goldstein E; Kirkcaldy RD; Reshef D; Berman S; Weinstock H; Sabeti P; Del Rio C; Hall G; Hook EW; Lipsitch M
Emerg Infect Dis; 2012 Aug; 18(8):1290-7. PubMed ID: 22840274
[TBL] [Abstract][Full Text] [Related]
28. Escalation in the relative prevalence of ciprofloxacin-resistant gonorrhoea among men with urethral discharge in two South African cities: association with HIV seropositivity.
Lewis DA; Scott L; Slabbert M; Mhlongo S; van Zijl A; Sello M; du Plessis N; Radebe F; Wasserman E
Sex Transm Infect; 2008 Oct; 84(5):352-5. PubMed ID: 18596070
[TBL] [Abstract][Full Text] [Related]
29. From the Centers for Disease Control and Prevention. Fluoroquinolone resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
JAMA; 2000 Oct; 284(15):1917-9. PubMed ID: 11183745
[No Abstract] [Full Text] [Related]
30. Neisseria gonorrhoeae with decreased susceptibility to ciprofloxacin in British Columbia: an imported phenomenon.
Patrick D; Shaw C; Rekart ML
Can Commun Dis Rep; 1995 Aug; 21(15):137-9. PubMed ID: 7550049
[No Abstract] [Full Text] [Related]
31. The epidemiology of ciprofloxacin resistant isolates of Neisseria gonorrhoeae in Scotland 2002: a comparison of phenotypic and genotypic analysis.
Palmer HM; Young H; Martin IM; Ison CA; Spratt BG
Sex Transm Infect; 2005 Oct; 81(5):403-7. PubMed ID: 16199740
[TBL] [Abstract][Full Text] [Related]
32. Importation into the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline.
Turner A; Gough KR; Jephcott AE; McClean AN
Genitourin Med; 1995 Oct; 71(5):331-2. PubMed ID: 7490059
[No Abstract] [Full Text] [Related]
33. Increasing resistance to ciprofloxacin among isolates of Neisseria gonorrhoea in Dublin.
Hopkins S; Coleman C; Kelleher M; Keating S; Clarke S; O'Connell B; Mulcahy F; Bergin C
Ir Med J; 2005; 98(7):208-9. PubMed ID: 16185017
[TBL] [Abstract][Full Text] [Related]
34. Ciprofloxacin resistant Neisseria gonorrhoeae.
Thompson C; Young H; Moyes A
Genitourin Med; 1995 Dec; 71(6):412-3. PubMed ID: 8566988
[No Abstract] [Full Text] [Related]
35. Emergence of fluoroquinolone resistant Neisseria gonorrhoeae in New Delhi, India.
Rattan A; Kumari S; Khanna N; Pandhi RK; Ray K; Bala M; Misra RS
Sex Transm Infect; 1998 Jun; 74(3):229. PubMed ID: 9849566
[No Abstract] [Full Text] [Related]
36. Multiclonal increase in ciprofloxacin-resistant Neisseria gonorrhoeae, Thailand, 1998-1999.
Trees DL; Sirivongrangson P; Schultz AJ; Buatiang A; Neal SW; Knapp JS; Kilmarx PH
Sex Transm Dis; 2002 Nov; 29(11):668-73. PubMed ID: 12438903
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.
Yang Y; Liao M; Gu WM; Bell K; Wu L; Eng NF; Zhang CG; Chen Y; Jolly AM; Dillon JA
J Antimicrob Chemother; 2006 Oct; 58(4):868-72. PubMed ID: 16880174
[TBL] [Abstract][Full Text] [Related]
38. Ciprofloxacin resistance in Neisseria gonorrhoeae isolated in Mumbai (formerly Bombay), India.
Divekar A; Gogate A
Sex Transm Infect; 1999 Apr; 75(2):122. PubMed ID: 10448368
[No Abstract] [Full Text] [Related]
39. Gonorrhoea treatment failure and ciprofloxacin resistance.
Ng PP; Chan RK; Ling AE
Int J STD AIDS; 1998 Jun; 9(6):323-5. PubMed ID: 9671244
[TBL] [Abstract][Full Text] [Related]
40. Ciprofloxacin resistance in gonococci.
Ison C; Martin I; Ivens D; Philip S; Greene L
Lancet; 2001 Mar; 357(9258):803. PubMed ID: 11253997
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
